60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed May 15, 2024 · 10-Q · 45 days after period end · 0001213900-24-043323
| Metric | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|
| Revenue | $105.67K | $17.17K | — |
| Net Income | $430.47K | -$2.60M | -$907.45K |
| EPS Diluted | $1.83 | -$1.13 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end
